指南与共识皮肤肿瘤

Gorlin综合征基底细胞癌管理临床实践指南

Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.
指南 / 共识 · J Am Acad Dermatol · 2025-10-25

该指南由多学科专家组采用改良GRADE方法,整合系统评价、专家调查、患者访谈和Delphi共识,制定了Gorlin综合征中基底细胞癌管理的47条推荐,涵盖局部治疗、全身治疗、手术干预及多模式策略,并强调共同决策、全面监测和心理社会支持。

要点

  • 推荐使用Hedgehog抑制剂和局部场治疗以减少手术疲劳并提高生活质量。
  • 指南强调共同决策、全面监测和心理社会支持以应对BCC的慢性病程。
  • 因GS特异性数据稀缺,部分推荐基于专家共识,需持续研究强化证据。

核心结论

  • 该指南为Gorlin综合征中基底细胞癌的管理提供了结构化框架,旨在改善临床结局和患者生活质量。

研究设计与样本

  • 多学科专家组采用改良的推荐分级的评估、制定与评价(GRADE)方法,整合系统评价、专家调查、患者访谈和Delphi共识轮次制定推荐。

主要发现

  • 最终指南包含47条推荐,涵盖局部治疗、全身治疗、手术干预和多模式策略。
  • 额外推荐强调共同决策、全面监测和心理社会支持,以应对Gorlin综合征中基底细胞癌的慢性特性。
  • 推荐特定疗法包括Hedgehog抑制剂和局部场治疗,以减少手术疲劳并提高生活质量。

关键数值与推荐

  • 指南共形成47条推荐,涉及局部治疗、全身治疗、手术干预及多模式策略。
  • 推荐Hedgehog抑制剂和局部场治疗以减少手术疲劳并提高生活质量。
  • 推荐共同决策、全面监测和心理社会支持。

临床怎么用

  • 临床中可依据47条推荐对Gorlin综合征患者的基底细胞癌进行局部、全身、手术及多模式治疗决策。
  • 应重视共同决策、全面监测和心理社会支持,并考虑使用Hedgehog抑制剂和局部场治疗以减少手术疲劳。

局限性

  • 鉴于Gorlin综合征特异性数据稀缺,部分推荐基于专家共识,需要持续研究以强化证据基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gorlin syndrome (GS) is a rare genetic disorder characterized by a predisposition to developing numerous basal cell carcinomas (BCCs) throughout life. The absence of specific clinical guidelines for managing BCCs in GS has resulted in fragmented care and inconsistent treatment approaches. OBJECTIVE: To develop evidence-based guidelines for managing BCCs in GS, addressing both clinical and psychosocial challenges. METHODS: A multidisciplinary panel employed a modified Grading of Recommendations Assessment, Development and Evaluation approach, integrating systematic reviews, expert surveys, patient interviews, and Delphi consensus rounds to formulate recommendations. RESULTS: The final guidelines include 47 recommendations spanning topical therapies, systemic treatments, surgical interventions, and multimodal strategies. Additional recommendations emphasize shared decision-making, comprehensive monitoring, and psychosocial support to address the chronic nature of BCCs in GS. Specific therapies, including hedgehog inhibitors and field treatments, are recommended to reduce surgical fatigue and enhance quality of life. LIMITATIONS: Given the scarcity of GS-specific data, expert consensus informed several recommendations, highlighting the need for ongoing research to strengthen the evidence base. CONCLUSION: These guidelines provide a structured framework for improving BCC management in GS, thereby enhancing clinical outcomes and patient quality of life. This process serves as a model for creating patient-centered guidelines in rare conditions with limited evidence.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Cahn BA, Zhang R, Sidwell AM, et al. Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome. J Am Acad Dermatol. 2025. PMID: 41396574. doi:10.1016/j.jaad.2025.10.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。